A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors

Clinical trial NCT07288957 · RECRUITING

Trial details

NCT number: NCT07288957
Sponsor: Abbisko Therapeutics Co, Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors (Phase 1)

Start date: 2025-07-22
Primary completion: 2028-12-30
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.